IMP
Process View
erythrocyte homeostasis
Any process of regulating the production and elimination of erythrocytes within an organism.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "erythrocyte homeostasis"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| TAL1 | T-cell acute lymphocytic leukemia 1 | 1.000 | ||
| CREBBP | CREB binding protein | 0.999 | ||
| SMAD2 | SMAD family member 2 | 0.979 | ||
| JUN | jun proto-oncogene | 0.960 | ||
| RUNX1 | runt-related transcription factor 1 | 0.939 | ||
| TCF3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | 0.904 | ||
| CREB1 | cAMP responsive element binding protein 1 | 0.827 | ||
| HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.807 | Mouse | |
| EP300 | E1A binding protein p300 | 0.807 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.798 | ||
| NCOA6 | nuclear receptor coactivator 6 | 0.769 | ||
| GATA1 | GATA binding protein 1 (globin transcription factor 1) | 0.757 | ||
| DYRK1A | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A | 0.667 | Human | |
| RPS16 | ribosomal protein S16 | 0.637 | ||
| HOXB5 | homeobox B5 | 0.624 | Human | |
| KLF6 | Kruppel-like factor 6 | 0.612 | Human | |
| DDIT3 | DNA-damage-inducible transcript 3 | 0.593 | ||
| SMAD3 | SMAD family member 3 | 0.489 | ||
| RPS10 | ribosomal protein S10 | 0.480 | ||
| NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 | 0.453 | ||
| INSR | insulin receptor | 0.450 | ||
| RPS2 | ribosomal protein S2 | 0.447 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.446 | ||
| RPS19 | ribosomal protein S19 | 0.440 | ||
| GHR | growth hormone receptor | 0.433 | ||
| CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.432 | ||
| DUSP1 | dual specificity phosphatase 1 | 0.425 | ||
| TCF12 | transcription factor 12 | 0.406 | ||
| SMAD7 | SMAD family member 7 | 0.393 | ||
| NCOA3 | nuclear receptor coactivator 3 | 0.380 | ||
| ATF3 | activating transcription factor 3 | 0.349 | ||
| TP53 | tumor protein p53 | 0.337 | ||
| CDK2 | cyclin-dependent kinase 2 | 0.298 | ||
| GATA2 | GATA binding protein 2 | 0.275 | Human Zebrafish Mouse | |
| HOXA5 | homeobox A5 | 0.273 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.272 | ||
| ANK1 | ankyrin 1, erythrocytic | 0.258 | Mouse | |
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.258 | Human | |
| NCOA2 | nuclear receptor coactivator 2 | 0.246 | ||
| HOXA10 | homeobox A10 | 0.242 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.237 | ||
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.231 | ||
| APAF1 | apoptotic peptidase activating factor 1 | 0.229 | ||
| ELAVL1 | ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R) | 0.224 | ||
| SLC4A1 | solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group) | 0.222 | ||
| CCND1 | cyclin D1 | 0.220 | ||
| KLF4 | Kruppel-like factor 4 (gut) | 0.219 | Human | |
| KHDRBS1 | KH domain containing, RNA binding, signal transduction associated 1 | 0.218 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.214 | ||
| RHAG | Rh-associated glycoprotein | 0.210 | Mouse | |
| BACH1 | BTB and CNC homology 1, basic leucine zipper transcription factor 1 | 0.206 | ||
| SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.206 | ||
| RPL27 | ribosomal protein L27 | 0.197 | ||
| FKBP1A | FK506 binding protein 1A, 12kDa | 0.186 | ||
| PARK2 | parkinson protein 2, E3 ubiquitin protein ligase (parkin) | 0.185 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.164 | ||
| RPLP2 | ribosomal protein, large, P2 | 0.161 | ||
| MAFG | v-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian) | 0.160 | Human | |
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.159 | Human | |
| RPS15 | ribosomal protein S15 | 0.149 | ||
| MYOD1 | myogenic differentiation 1 | 0.148 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.146 | ||
| SP100 | SP100 nuclear antigen | 0.142 | ||
| SPTB | spectrin, beta, erythrocytic | 0.141 | ||
| NFIL3 | nuclear factor, interleukin 3 regulated | 0.140 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.137 | Human | |
| AR | androgen receptor | 0.133 | ||
| LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.130 | ||
| JAK2 | Janus kinase 2 | 0.129 | Mouse | |
| ARID4B | AT rich interactive domain 4B (RBP1-like) | 0.128 | ||
| SP1 | Sp1 transcription factor | 0.127 | Mouse | |
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.124 | ||
| RPS27 | ribosomal protein S27 | 0.124 | ||
| SUMO3 | SMT3 suppressor of mif two 3 homolog 3 (S. cerevisiae) | 0.123 | ||
| SMARCE1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 | 0.122 | ||
| PPP1R15A | protein phosphatase 1, regulatory (inhibitor) subunit 15A | 0.122 | ||
| MAFB | v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) | 0.115 | ||
| SIRT1 | sirtuin 1 | 0.115 | ||
| ATF4 | activating transcription factor 4 (tax-responsive enhancer element B67) | 0.115 | ||
| SMAD4 | SMAD family member 4 | 0.110 | ||
| RPS6 | ribosomal protein S6 | 0.109 | Mouse | |
| SETD8 | SET domain containing (lysine methyltransferase) 8 | 0.109 | ||
| RBPMS | RNA binding protein with multiple splicing | 0.105 | ||
| GAS6 | growth arrest-specific 6 | 0.104 | ||
| GATA4 | GATA binding protein 4 | 0.101 | Human | |
| RPS5 | ribosomal protein S5 | 0.100 | ||
| RPS11 | ribosomal protein S11 | 0.099 | ||
| SH2D4A | SH2 domain containing 4A | 0.098 | ||
| RPL36 | ribosomal protein L36 | 0.093 | ||
| HBG2 | hemoglobin, gamma G | 0.092 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.092 | ||
| RPS7 | ribosomal protein S7 | 0.092 | ||
| RPS23 | ribosomal protein S23 | 0.085 | ||
| CFLAR | CASP8 and FADD-like apoptosis regulator | 0.079 | ||
| GABPA | GA binding protein transcription factor, alpha subunit 60kDa | 0.077 | ||
| RPL23A | ribosomal protein L23a | 0.076 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.075 | ||
| EGLN1 | egl nine homolog 1 (C. elegans) | 0.074 | ||
| CRADD | CASP2 and RIPK1 domain containing adaptor with death domain | 0.073 | ||
| U2AF1 | U2 small nuclear RNA auxiliary factor 1 | 0.073 | ||
| CDKN1B | cyclin-dependent kinase inhibitor 1B (p27, Kip1) | 0.073 | ||
| HOXB6 | homeobox B6 | 0.073 | Human Mouse | |
| LZTS2 | leucine zipper, putative tumor suppressor 2 | 0.072 | ||
| KLF13 | Kruppel-like factor 13 | 0.071 | Mouse | |
| HOXA7 | homeobox A7 | 0.070 | Human | |
| MAF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian) | 0.070 | Human | |
| SP3 | Sp3 transcription factor | 0.070 | Mouse | |
| NMI | N-myc (and STAT) interactor | 0.069 | ||
| MYST3 | MYST histone acetyltransferase (monocytic leukemia) 3 | 0.069 | ||
| RPS4X | ribosomal protein S4, X-linked | 0.068 | ||
| DYRK2 | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 | 0.066 | Human | |
| LDLR | low density lipoprotein receptor | 0.066 | ||
| AHR | aryl hydrocarbon receptor | 0.065 | ||
| RPS13 | ribosomal protein S13 | 0.065 | ||
| LMO4 | LIM domain only 4 | 0.064 | ||
| ALAS2 | aminolevulinate, delta-, synthase 2 | 0.064 | Mouse | |
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.063 | ||
| GAS7 | growth arrest-specific 7 | 0.063 | ||
| HOXA11 | homeobox A11 | 0.059 | ||
| RHD | Rh blood group, D antigen | 0.058 | Mouse | |
| ARID2 | AT rich interactive domain 2 (ARID, RFX-like) | 0.058 | ||
| RPS14 | ribosomal protein S14 | 0.057 | ||
| RFWD2 | ring finger and WD repeat domain 2 | 0.057 | ||
| QKI | quaking homolog, KH domain RNA binding (mouse) | 0.056 | ||
| ARNT | aryl hydrocarbon receptor nuclear translocator | 0.056 | ||
| LMO2 | LIM domain only 2 (rhombotin-like 1) | 0.056 | Mouse | |
| DAXX | death-domain associated protein | 0.056 | ||
| MYL4 | myosin, light chain 4, alkali; atrial, embryonic | 0.054 | ||
| HOXB3 | homeobox B3 | 0.054 | ||
| HOXB9 | homeobox B9 | 0.054 | ||
| GYPB | glycophorin B (MNS blood group) | 0.053 | ||
| SMAD1 | SMAD family member 1 | 0.052 | ||
| RFX1 | regulatory factor X, 1 (influences HLA class II expression) | 0.052 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.051 | ||
| MAFA | v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (avian) | 0.050 | ||
| BRD4 | bromodomain containing 4 | 0.050 | ||
| HOXA4 | homeobox A4 | 0.049 | Human | |
| HBZ | hemoglobin, zeta | 0.048 | Mouse | |
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.048 | ||
| GSK3B | glycogen synthase kinase 3 beta | 0.048 | ||
| RPS12 | ribosomal protein S12 | 0.047 | ||
| SH2B1 | SH2B adaptor protein 1 | 0.047 | ||
| BIRC5 | baculoviral IAP repeat containing 5 | 0.046 | ||
| SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.046 | ||
| SH3BP4 | SH3-domain binding protein 4 | 0.045 | ||
| STAT1 | signal transducer and activator of transcription 1, 91kDa | 0.044 | ||
| RPS15A | ribosomal protein S15a | 0.044 | ||
| YY1 | YY1 transcription factor | 0.043 | ||
| VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.043 | ||
| GDF5 | growth differentiation factor 5 | 0.043 | ||
| RPS3 | ribosomal protein S3 | 0.043 | Zebrafish | |
| MKL1 | megakaryoblastic leukemia (translocation) 1 | 0.040 | ||
| E2F1 | E2F transcription factor 1 | 0.039 | ||
| IRS1 | insulin receptor substrate 1 | 0.039 | ||
| MYOCD | myocardin | 0.038 | ||
| PML | promyelocytic leukemia | 0.037 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.037 | ||
| RPS29 | ribosomal protein S29 | 0.037 | Zebrafish | |
| EPB42 | erythrocyte membrane protein band 4.2 | 0.037 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.037 | ||
| RPL38 | ribosomal protein L38 | 0.037 | ||
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.036 | Human | |
| TPI1 | triosephosphate isomerase 1 | 0.036 | ||
| IFNGR1 | interferon gamma receptor 1 | 0.035 | ||
| IRS2 | insulin receptor substrate 2 | 0.035 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.035 | ||
| JUND | jun D proto-oncogene | 0.034 | ||
| MED13 | mediator complex subunit 13 | 0.034 | ||
| TXN | thioredoxin | 0.034 | ||
| KLF1 | Kruppel-like factor 1 (erythroid) | 0.033 | ||
| HOXC10 | homeobox C10 | 0.033 | ||
| STAT5A | signal transducer and activator of transcription 5A | 0.033 | Zebrafish Mouse | |
| HSPA1A | heat shock 70kDa protein 1A | 0.033 | ||
| IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.033 | ||
| WHSC1L1 | Wolf-Hirschhorn syndrome candidate 1-like 1 | 0.033 | ||
| KITLG | KIT ligand | 0.032 | ||
| RXRA | retinoid X receptor, alpha | 0.032 | ||
| IRF3 | interferon regulatory factor 3 | 0.031 | ||
| KEAP1 | kelch-like ECH-associated protein 1 | 0.030 | ||
| VEGFA | vascular endothelial growth factor A | 0.030 | Mouse | |
| BAG3 | BCL2-associated athanogene 3 | 0.029 | ||
| RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.029 | ||
| EFCAB4B | EF-hand calcium binding domain 4B | 0.029 | ||
| FBXO7 | F-box protein 7 | 0.028 | ||
| RPS21 | ribosomal protein S21 | 0.028 | ||
| DYRK4 | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4 | 0.028 | Human | |
| PDX1 | pancreatic and duodenal homeobox 1 | 0.028 | ||
| HOXA9 | homeobox A9 | 0.028 | ||
| RHCE | Rh blood group, CcEe antigens | 0.028 | Mouse | |
| RPS3A | ribosomal protein S3A | 0.028 | ||
| ETS2 | v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) | 0.028 | Human | |
| RPL24 | ribosomal protein L24 | 0.028 | ||
| CASK | calcium/calmodulin-dependent serine protein kinase (MAGUK family) | 0.028 | ||
| ELF4 | E74-like factor 4 (ets domain transcription factor) | 0.028 | ||
| SPTA1 | spectrin, alpha, erythrocytic 1 (elliptocytosis 2) | 0.028 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.028 | ||
| HOXA2 | homeobox A2 | 0.027 | ||
| LEO1 | Leo1, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae) | 0.027 | ||
| RANBP9 | RAN binding protein 9 | 0.027 | ||
| EPOR | erythropoietin receptor | 0.027 | ||
| HSPB1 | heat shock 27kDa protein 1 | 0.026 | ||
| HMGB2 | high mobility group box 2 | 0.026 | ||
| HOXD12 | homeobox D12 | 0.026 | ||
| POU2F1 | POU class 2 homeobox 1 | 0.026 | ||
| PCDH9 | protocadherin 9 | 0.026 | ||
| SMAD6 | SMAD family member 6 | 0.026 | ||
| RIOK3 | RIO kinase 3 (yeast) | 0.026 | ||
| HOXA6 | homeobox A6 | 0.025 | Human | |
| CUX1 | cut-like homeobox 1 | 0.025 | ||
| RPS18 | ribosomal protein S18 | 0.025 | ||
| BMP2 | bone morphogenetic protein 2 | 0.024 | ||
| RPS25 | ribosomal protein S25 | 0.024 | ||
| USP18 | ubiquitin specific peptidase 18 | 0.024 | ||
| OBSCN | obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF | 0.024 | ||
| HMGB1 | high mobility group box 1 | 0.024 | Human | |
| PPARA | peroxisome proliferator-activated receptor alpha | 0.024 | ||
| RARA | retinoic acid receptor, alpha | 0.024 | ||
| SMPD1 | sphingomyelin phosphodiesterase 1, acid lysosomal | 0.023 | ||
| EHMT2 | euchromatic histone-lysine N-methyltransferase 2 | 0.023 | ||
| HOXB7 | homeobox B7 | 0.023 | Human | |
| XRCC6 | X-ray repair complementing defective repair in Chinese hamster cells 6 | 0.022 | ||
| CTBP1 | C-terminal binding protein 1 | 0.022 | ||
| GCC1 | GRIP and coiled-coil domain containing 1 | 0.022 | ||
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.022 | ||
| SFRP5 | secreted frizzled-related protein 5 | 0.022 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.022 | ||
| ZCCHC17 | zinc finger, CCHC domain containing 17 | 0.022 | ||
| HOXC6 | homeobox C6 | 0.021 | Human | |
| HDAC1 | histone deacetylase 1 | 0.021 | ||
| SMURF1 | SMAD specific E3 ubiquitin protein ligase 1 | 0.021 | ||
| NUCKS1 | nuclear casein kinase and cyclin-dependent kinase substrate 1 | 0.021 | ||
| EGR1 | early growth response 1 | 0.021 | ||
| OSBP2 | oxysterol binding protein 2 | 0.021 | ||
| HBE1 | hemoglobin, epsilon 1 | 0.021 | ||
| CASP7 | caspase 7, apoptosis-related cysteine peptidase | 0.020 | Human | |
| SSBP2 | single-stranded DNA binding protein 2 | 0.020 | ||
| CBX5 | chromobox homolog 5 | 0.020 | ||
| EIF2AK2 | eukaryotic translation initiation factor 2-alpha kinase 2 | 0.020 | ||
| TWIST2 | twist homolog 2 (Drosophila) | 0.020 | ||
| FOXO3 | forkhead box O3 | 0.020 | ||
| UPP1 | uridine phosphorylase 1 | 0.020 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.020 | ||
| LMNB1 | lamin B1 | 0.020 | ||
| LYL1 | lymphoblastic leukemia derived sequence 1 | 0.020 | Human | |
| TCF4 | transcription factor 4 | 0.020 | ||
| FOXO1 | forkhead box O1 | 0.019 | Human | |
| PTMA | prothymosin, alpha | 0.019 | ||
| CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | 0.019 | ||
| POLR2A | polymerase (RNA) II (DNA directed) polypeptide A, 220kDa | 0.019 | ||
| ABI1 | abl-interactor 1 | 0.019 | ||
| RPS9 | ribosomal protein S9 | 0.019 | ||
| CBLB | Cas-Br-M (murine) ecotropic retroviral transforming sequence b | 0.019 | ||
| ID3 | inhibitor of DNA binding 3, dominant negative helix-loop-helix protein | 0.019 | ||
| TAF6L | TAF6-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa | 0.019 | ||
| ADNP | activity-dependent neuroprotector homeobox | 0.019 | ||
| AURKB | aurora kinase B | 0.019 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.019 | ||
| KEL | Kell blood group, metallo-endopeptidase | 0.019 | ||
| TFAP2A | transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) | 0.018 | ||
| INCENP | inner centromere protein antigens 135/155kDa | 0.018 | ||
| UBR5 | ubiquitin protein ligase E3 component n-recognin 5 | 0.018 | ||
| PPP1CC | protein phosphatase 1, catalytic subunit, gamma isozyme | 0.018 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.018 | ||
| NFE2 | nuclear factor (erythroid-derived 2), 45kDa | 0.018 | ||
| POU5F1 | POU class 5 homeobox 1 | 0.018 | ||
| WWP1 | WW domain containing E3 ubiquitin protein ligase 1 | 0.018 | ||
| CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.018 | Human | |
| IFNAR2 | interferon (alpha, beta and omega) receptor 2 | 0.017 | ||
| UBE2I | ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) | 0.017 | ||
| KIF20A | kinesin family member 20A | 0.017 | ||
| DYRK1B | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B | 0.017 | Human | |
| FAS | Fas (TNF receptor superfamily, member 6) | 0.017 | ||
| MED13L | mediator complex subunit 13-like | 0.017 | ||
| FOSL2 | FOS-like antigen 2 | 0.017 | ||
| HTT | huntingtin | 0.017 | ||
| RPS20 | ribosomal protein S20 | 0.017 | ||
| MAP1LC3B | microtubule-associated protein 1 light chain 3 beta | 0.017 | ||
| NOTCH1 | notch 1 | 0.017 | ||
| PRKG1 | protein kinase, cGMP-dependent, type I | 0.017 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.017 | ||
| NRP1 | neuropilin 1 | 0.016 | ||
| TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.016 | ||
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.016 | ||
| PIAS1 | protein inhibitor of activated STAT, 1 | 0.016 | ||
| PGF | placental growth factor | 0.016 | ||
| ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.016 | ||
| LAT | linker for activation of T cells | 0.016 | ||
| CDCA8 | cell division cycle associated 8 | 0.016 | ||
| HAND2 | heart and neural crest derivatives expressed 2 | 0.016 | Human | |
| IL4R | interleukin 4 receptor | 0.016 | ||
| E2F3 | E2F transcription factor 3 | 0.016 | ||
| GGH | gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase) | 0.016 | ||
| SOS1 | son of sevenless homolog 1 (Drosophila) | 0.016 | ||
| ADM | adrenomedullin | 0.016 | ||
| CBFA2T3 | core-binding factor, runt domain, alpha subunit 2; translocated to, 3 | 0.016 | ||
| HOXC4 | homeobox C4 | 0.015 | Human | |
| SOX7 | SRY (sex determining region Y)-box 7 | 0.015 | ||
| CDK1 | cyclin-dependent kinase 1 | 0.015 | ||
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.015 | ||
| SPI1 | spleen focus forming virus (SFFV) proviral integration oncogene spi1 | 0.015 | ||
| DCAF7 | DDB1 and CUL4 associated factor 7 | 0.015 | ||
| MLL3 | myeloid/lymphoid or mixed-lineage leukemia 3 | 0.015 | ||
| RPS8 | ribosomal protein S8 | 0.015 | ||
| HOXA3 | homeobox A3 | 0.015 | ||
| FADD | Fas (TNFRSF6)-associated via death domain | 0.015 | ||
| HOXC11 | homeobox C11 | 0.015 | ||
| SOD1 | superoxide dismutase 1, soluble | 0.015 | ||
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.014 | ||
| CDK6 | cyclin-dependent kinase 6 | 0.014 | ||
| MAP3K1 | mitogen-activated protein kinase kinase kinase 1 | 0.014 | ||
| MEF2C | myocyte enhancer factor 2C | 0.014 | ||
| STAT5B | signal transducer and activator of transcription 5B | 0.014 | Zebrafish Mouse | |
| HNRNPK | heterogeneous nuclear ribonucleoprotein K | 0.014 | ||
| LRDD | leucine-rich repeats and death domain containing | 0.014 | ||
| WAC | WW domain containing adaptor with coiled-coil | 0.014 | ||
| RCC1 | regulator of chromosome condensation 1 | 0.014 | ||
| MEF2A | myocyte enhancer factor 2A | 0.014 | ||
| JUNB | jun B proto-oncogene | 0.014 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.014 | ||
| MEOX2 | mesenchyme homeobox 2 | 0.014 | ||
| FAM190B | family with sequence similarity 190, member B | 0.014 | ||
| HOXB4 | homeobox B4 | 0.014 | Human | |
| TGFB3 | transforming growth factor, beta 3 | 0.014 | ||
| MYOG | myogenin (myogenic factor 4) | 0.014 | ||
| MYCN | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | 0.014 | ||
| NFE2L1 | nuclear factor (erythroid-derived 2)-like 1 | 0.014 | Mouse | |
| RSBN1 | round spermatid basic protein 1 | 0.014 | ||
| TSC22D3 | TSC22 domain family, member 3 | 0.014 | ||
| MAP3K14 | mitogen-activated protein kinase kinase kinase 14 | 0.013 | ||
| RBFOX1 | RNA binding protein, fox-1 homolog (C. elegans) 1 | 0.013 | ||
| PSME2 | proteasome (prosome, macropain) activator subunit 2 (PA28 beta) | 0.013 | ||
| USP15 | ubiquitin specific peptidase 15 | 0.013 | ||
| ACVR1 | activin A receptor, type I | 0.013 | Human | |
| CEBPA | CCAAT/enhancer binding protein (C/EBP), alpha | 0.013 | ||
| SQSTM1 | sequestosome 1 | 0.013 | ||
| ZBTB41 | zinc finger and BTB domain containing 41 | 0.013 | ||
| CASP1 | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) | 0.013 | ||
| RPL18 | ribosomal protein L18 | 0.013 | ||
| MYO1G | myosin IG | 0.013 | ||
| EGFR | epidermal growth factor receptor | 0.013 | ||
| HBB | hemoglobin, beta | 0.013 | ||
| SYK | spleen tyrosine kinase | 0.013 | ||
| PLP2 | proteolipid protein 2 (colonic epithelium-enriched) | 0.013 | ||
| THRA | thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian) | 0.013 | Mouse | |
| ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 0.013 | ||
| PF4 | platelet factor 4 | 0.013 | ||
| ATF2 | activating transcription factor 2 | 0.012 | ||
| KCNH2 | potassium voltage-gated channel, subfamily H (eag-related), member 2 | 0.012 | ||
| GADD45B | growth arrest and DNA-damage-inducible, beta | 0.012 | ||
| RPL19 | ribosomal protein L19 | 0.012 | ||
| RPS17 | ribosomal protein S17 | 0.012 | ||
| PARK7 | Parkinson disease (autosomal recessive, early onset) 7 | 0.012 | ||
| SOS2 | son of sevenless homolog 2 (Drosophila) | 0.012 | ||
| BAG1 | BCL2-associated athanogene | 0.012 | ||
| DOK3 | docking protein 3 | 0.012 | ||
| RAB8A | RAB8A, member RAS oncogene family | 0.012 | ||
| FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) | 0.012 | ||
| RPL28 | ribosomal protein L28 | 0.012 | ||
| SH3BGRL3 | SH3 domain binding glutamic acid-rich protein like 3 | 0.012 | ||
| HOXC5 | homeobox C5 | 0.012 | Human | |
| BAZ1B | bromodomain adjacent to zinc finger domain, 1B | 0.012 | ||
| SMARCA2 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 | 0.012 | ||
| SLAMF1 | signaling lymphocytic activation molecule family member 1 | 0.012 | ||
| SMARCC1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 | 0.012 | ||
| NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.012 | ||
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.012 | ||
| HMGXB4 | HMG box domain containing 4 | 0.012 | ||
| MTHFD2 | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase | 0.012 | ||
| ZNF217 | zinc finger protein 217 | 0.012 | ||
| PPAP2B | phosphatidic acid phosphatase type 2B | 0.012 | ||
| CHD3 | chromodomain helicase DNA binding protein 3 | 0.012 | ||
| FBXO11 | F-box protein 11 | 0.012 | ||
| WDR1 | WD repeat domain 1 | 0.012 | ||
| ESR1 | estrogen receptor 1 | 0.012 | ||
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.012 | ||
| HMGN1 | high mobility group nucleosome binding domain 1 | 0.012 | ||
| NUSAP1 | nucleolar and spindle associated protein 1 | 0.012 | ||
| RPL6 | ribosomal protein L6 | 0.011 | ||
| ZFPM1 | zinc finger protein, multitype 1 | 0.011 | ||
| RAP1GAP | RAP1 GTPase activating protein | 0.011 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.011 | ||
| HOXB13 | homeobox B13 | 0.011 | ||
| ID2 | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein | 0.011 | Mouse | |
| GYPA | glycophorin A (MNS blood group) | 0.011 | ||
| HBP1 | HMG-box transcription factor 1 | 0.011 | ||
| HMGN2 | high mobility group nucleosomal binding domain 2 | 0.011 | ||
| ABCF3 | ATP-binding cassette, sub-family F (GCN20), member 3 | 0.011 | ||
| HDAC9 | histone deacetylase 9 | 0.011 | ||
| RBBP5 | retinoblastoma binding protein 5 | 0.011 | ||
| BCR | breakpoint cluster region | 0.011 | ||
| ERRFI1 | ERBB receptor feedback inhibitor 1 | 0.011 | ||
| CSRNP1 | cysteine-serine-rich nuclear protein 1 | 0.011 | ||
| KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.011 | Mouse | |
| RPL21 | ribosomal protein L21 | 0.011 | ||
| LDHA | lactate dehydrogenase A | 0.011 | ||
| LHX5 | LIM homeobox 5 | 0.011 | ||
| RPS24 | ribosomal protein S24 | 0.011 | ||
| STAT6 | signal transducer and activator of transcription 6, interleukin-4 induced | 0.011 | ||
| HOXC8 | homeobox C8 | 0.011 | Human | |
| HOXA1 | homeobox A1 | 0.011 | ||
| REST | RE1-silencing transcription factor | 0.011 | ||
| NR3C1 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.011 | ||
| AP2M1 | adaptor-related protein complex 2, mu 1 subunit | 0.011 | ||
| HBA2 | hemoglobin, alpha 2 | 0.011 | Mouse | |
| JAK1 | Janus kinase 1 | 0.011 | ||
| RPL9 | ribosomal protein L9 | 0.011 | ||
| HOXB2 | homeobox B2 | 0.011 | ||
| MEIS1 | Meis homeobox 1 | 0.011 | Zebrafish | |
| FOXB1 | forkhead box B1 | 0.011 | ||
| HOXA13 | homeobox A13 | 0.011 | ||
| HSPA6 | heat shock 70kDa protein 6 (HSP70B') | 0.011 | Human | |
| HBQ1 | hemoglobin, theta 1 | 0.010 | ||
| TUBB2C | tubulin, beta 2C | 0.010 | ||
| SAP30BP | SAP30 binding protein | 0.010 | ||
| MKL2 | MKL/myocardin-like 2 | 0.010 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.010 | ||
| PAX5 | paired box 5 | 0.010 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.010 | ||
| SAFB | scaffold attachment factor B | 0.010 | ||
| AKAP13 | A kinase (PRKA) anchor protein 13 | 0.010 | ||
| VEZF1 | vascular endothelial zinc finger 1 | 0.010 | ||
| FAM134A | family with sequence similarity 134, member A | 0.010 | ||
| ERG | v-ets erythroblastosis virus E26 oncogene homolog (avian) | 0.010 | ||
| KDM2A | lysine (K)-specific demethylase 2A | 0.010 | ||
| HOXC9 | homeobox C9 | 0.010 | ||
| IL2RB | interleukin 2 receptor, beta | 0.010 | ||
| ZSCAN16 | zinc finger and SCAN domain containing 16 | 0.010 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.010 |